U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech

Per NPR News, the U.S. Army's missile stockpile is dwindling and could require years to replenish. Separately, the Food and Drug Administration is weighing whether to approve a flu vaccine using mRNA technology.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton